Yüklüyor......
Ustekinumab in Crohn’s disease: evidence to date and place in therapy
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) with uncertain etiology. Biologic agents have revolutionized the treatment of CD but nonresponders remain a challenge. Ustekinumab is an interleukin 12/23p40 inhibitor that was recently found effective in treating CD. We reviewed the curren...
Kaydedildi:
| Yayımlandı: | Ther Adv Chronic Dis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935835/ https://ncbi.nlm.nih.gov/pubmed/27433311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316653306 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|